Literature DB >> 30051922

Microglia have a more extensive and divergent response to interferon-α compared with astrocytes.

Wen Li1, Barney Viengkhou1,2, Gareth Denyer2, Phillip K West1,2, Iain L Campbell1, Markus J Hofer1,2.   

Abstract

Type I interferons (IFN-I) are crucial for effective antimicrobial defense in the central nervous system (CNS) but also can cause severe neurological disease (termed cerebral interferonopathy) as exemplified by Aicardi-Goutières Syndrome. In the CNS, microglia and astrocytes have essential roles in host responses to infection and injury, with both cell types responding to IFN-I. While the IFN-I signaling pathways are the same in astrocytes and microglia, the extent to which the IFN-I responses of these cells differ, if at all, is unknown. Here we determined the global transcriptional responses of astrocytes and microglia to the IFN-I, IFN-α. We found that under basal conditions, each cell type has a unique gene expression pattern reflective of its developmental origin and biological function. Following stimulation with IFN-α, astrocytes and microglia also displayed a common core response that was characterized by the increased expression of genes required for pathogen detection and elimination. Compared with astrocytes, microglia had a more extensive and diverse response to IFN-α with significantly more genes with expression upregulated (282 vs. 141) and downregulated (81 vs. 3). Further validation was documented for selected IFN-I-regulated genes in a murine model of cerebral interferonopathy. In all, the findings highlight not only overlapping but importantly divergent responses to IFN-I by astrocytes versus microglia. This suggests specialized roles for these cells in host defense and in the development of cerebral interferonopathy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  astrocyte; cerebral interferonopathies; interferon-alpha; microarray; microglia

Mesh:

Substances:

Year:  2018        PMID: 30051922     DOI: 10.1002/glia.23460

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  11 in total

1.  CPEB1 regulates the inflammatory immune response, phagocytosis, and alternative polyadenylation in microglia.

Authors:  Maria P Ivshina; Heleen M van 't Spijker; Suna Jung; Sithara Raju Ponny; Dorothy P Schafer; Joel D Richter
Journal:  Glia       Date:  2022-05-30       Impact factor: 8.073

2.  Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques.

Authors:  Ethan R Roy; Gabriel Chiu; Sanming Li; Nicholas E Propson; Rupa Kanchi; Baiping Wang; Cristian Coarfa; Hui Zheng; Wei Cao
Journal:  Immunity       Date:  2022-04-19       Impact factor: 43.474

Review 3.  The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders.

Authors:  Wenqun Li; Jiaqin Liu; Wei Tan; Yedi Zhou
Journal:  Int J Med Sci       Date:  2021-06-16       Impact factor: 3.738

4.  Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

Authors:  Ethan R Roy; Baiping Wang; Ying-Wooi Wan; Gabriel Chiu; Allysa Cole; Zhuoran Yin; Nicholas E Propson; Yin Xu; Joanna L Jankowsky; Zhandong Liu; Virginia M-Y Lee; John Q Trojanowski; Stephen D Ginsberg; Oleg Butovsky; Hui Zheng; Wei Cao
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

5.  Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation.

Authors:  Nattayaporn Apaijai; Dalila Monica Moisescu; Siripong Palee; Christian Mervyn McSweeney; Napatsorn Saiyasit; Chayodom Maneechote; Chiraphat Boonnag; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

Review 6.  Astrocyte-Oligodendrocyte-Microglia Crosstalk in Astrocytopathies.

Authors:  Dieuwke Maria de Waard; Marianna Bugiani
Journal:  Front Cell Neurosci       Date:  2020-11-19       Impact factor: 5.505

7.  Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice.

Authors:  Feng Xue; Jing Tian; Chunxiao Yu; Heng Du; Lan Guo
Journal:  Neurobiol Dis       Date:  2021-02-01       Impact factor: 5.996

8.  A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells.

Authors:  Barney Viengkhou; Melanie Y White; Stuart J Cordwell; Iain L Campbell; Markus J Hofer
Journal:  J Neuroinflammation       Date:  2021-10-16       Impact factor: 8.322

9.  Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder.

Authors:  Jie Rao; Na Xu; Jing Sun; Yan Li; Fangwang Fu
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003

Review 10.  Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.

Authors:  Kim M A De Kleijn; Gerard J M Martens
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.